Christian Heidbreder
Chief Tech/Sci/R&D Officer bei INDIVIOR PLC
Vermögen: 2 Mio $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Christian Heidbreder
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
42
| Public Company | Pharmaceuticals: Major | 42 |
Medical College of Virginia
7
| College/University | Other Consumer Services | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christian Heidbreder
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
The Royal Horticultural Society
 The Royal Horticultural Society Miscellaneous Commercial ServicesCommercial Services The Royal Horticultural Society promotes horticulture for the benefit of local people and the environment. The non-profit company is based in London, UK and has subsidiaries in United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IKARIA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| ADIAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director of Finance/CFO Public Communications Contact | |
| KINGFISHER PLC | Home Improvement Chains | Corporate Secretary | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| BURBERRY GROUP PLC | Apparel/Footwear | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| Bryn Mawr College | College/University | Doctorate Degree | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
| Colgate University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Graduate Degree Graduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Virginia Commonwealth University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Sheffield | College/University | Undergraduate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Lincoln | College/University | Masters Business Admin | |
Virginia Biotechnology Association
 Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | Chairman Director of Finance/CFO President Chief Executive Officer President Director/Board Member General Counsel Human Resources Officer Corporate Officer/Principal | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Place2Be
 Place2Be Investment Trusts/Mutual FundsMiscellaneous Place2Be is a non-profit organization which provides emotional and therapeutic services in primary and secondary schools. It helps pupils to cope with often social issues including bullying, bereavement, domestic violence, family breakdown, neglect, and trauma. The company was founded by Dame Benita Refson in 1994 and is headquartered in London, the United Kingdom. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Baines Peter Consulting | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| BC Partners Foundation | Director/Board Member | ||
| Millbank Academy | Chief Executive Officer | ||
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Chairman | |
Reckitt Benckiser Health Ltd.
 Reckitt Benckiser Health Ltd. Medical DistributorsDistribution Services Founded in 2017, Reckitt Benckiser Health Ltd. is a subsidiary of Reckitt Benckiser Group Plc. The private company is based in Slough, UK. Reckitt Benckiser Health is home to the world's most loved and trusted hygiene, health, and nutrition brands. | Medical Distributors | Director/Board Member Director/Board Member | |
Indivior Uk Ltd.
 Indivior Uk Ltd. Pharmaceuticals: MajorHealth Technology Part of Indivior PLC, Indivior UK Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Hull, UK and was founded in 2010. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Future Academies
 Future Academies Miscellaneous Commercial ServicesCommercial Services Future Academies is an educational institution that operates several academies in the UK, including Barclay Academy, Churchill Gardens Primary Academy, Future Academies Watford, Laureate Academy, Millbank Academy, Phoenix Academy, Pimlico Primary, and The Grange Academy. The private company is based in London, UK. The institution offers a curriculum and co-curriculum that is designed to promote the values of Libertas per Cultum. Future Academies was founded by Caroline Nash, John A. Nash, and has been led by CEO Paul Smith since 2016. | Miscellaneous Commercial Services | Director/Board Member | |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| ILC Therapeutics Ltd. | Chairman |
Statistik
International
| Vereinigte Staaten | 19 |
| Vereinigtes Königreich | 18 |
| Indien | 5 |
| Frankreich | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Consumer Non-Durables | 3 |
| Retail Trade | 2 |
Operativ
| Director/Board Member | 203 |
| Corporate Officer/Principal | 108 |
| Independent Dir/Board Member | 70 |
| Undergraduate Degree | 26 |
| Chief Executive Officer | 25 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Adrian Hennah | 28 |
| Howard H. Pien | 27 |
| Lizabeth Zlatkus | 23 |
| Juliet Thompson | 22 |
| Peter Bains | 19 |
| Cary Claiborne | 19 |
| Barbara Ryan | 18 |
| Daniel Phelan | 17 |
| Christian Schade | 16 |
| Daniel Tassé | 16 |
| Yvonne Greenstreet | 15 |
| Rupert Bondy | 14 |
| Lorna Parker | 13 |
| Jerome Lande | 13 |
| Joanna Le Couilliard | 12 |
- Börse
- Insiders
- Christian Heidbreder
- Unternehmensverbindungen
